{"id":28488,"date":"2024-06-20T08:08:23","date_gmt":"2024-06-20T13:08:23","guid":{"rendered":"https:\/\/myeloma.ca\/?p=28488"},"modified":"2024-06-21T12:15:34","modified_gmt":"2024-06-21T17:15:34","slug":"le-profilage-tridimensionnel-des-telomeres-permet-de-predire-le-risque-de-progression-dun-myelome-multiple-indolent","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2024\/06\/20\/le-profilage-tridimensionnel-des-telomeres-permet-de-predire-le-risque-de-progression-dun-myelome-multiple-indolent\/","title":{"rendered":"Le profilage tridimensionnel des t\u00e9lom\u00e8res permet de pr\u00e9dire le risque de progression\u00a0d\u2019un my\u00e9lome multiple indolent\u00a0"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">\u00c0 ce jour, l\u2019identification des patients \u00e0 risque \u00e9lev\u00e9 de d\u00e9velopper un my\u00e9lome multiple indolent demeure un besoin clinique important. Dans cette \u00e9tude, nous pr\u00e9sentons le profilage 3D des t\u00e9lom\u00e8res \u00e0 titre de biomarqueur structurel capable de classer les patients atteints d\u2019un my\u00e9lome multiple indolent en fonction de leur instabilit\u00e9 g\u00e9nomique.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.27364\" target=\"_blank\" rel=\"noopener\" title=\"\">Lire la suite ici (en anglais seulement)&#8230;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c0 ce jour, l\u2019identification des patients \u00e0 risque \u00e9lev\u00e9 de d\u00e9velopper un my\u00e9lome multiple indolent demeure un besoin clinique important. Dans cette \u00e9tude, nous pr\u00e9sentons le profilage 3D des t\u00e9lom\u00e8res \u00e0 titre de biomarqueur structurel capable de classer les patients atteints d\u2019un my\u00e9lome multiple indolent en fonction de leur instabilit\u00e9 g\u00e9nomique. Lire la suite ici [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88,53],"tags":[],"class_list":["post-28488","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-evenement"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/28488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=28488"}],"version-history":[{"count":2,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/28488\/revisions"}],"predecessor-version":[{"id":28498,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/28488\/revisions\/28498"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=28488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=28488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=28488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}